Look at the peers. They are all essentially doing worse than CPST Changing mgt isn't the answer either. I'd agree with those that think mgt compensation should be the subject of scrutiny, but that's something I'd say is pretty much across the board for public companies. Buy it or not doesn't matter to me. CPST "should" be trading above $1 based on orders, cash on hand, potential in diversified markets, etc. Good buy point IMO.
News 
Market Data 
Discover 
